Tumour cell uptake of lactosaminated and intact N-succinylchitosans and antitumour effects of conjugates with mitomycin C

Yoshinori Kato, Hiraku Onishi, Yoshiharu Machida

Research output: Contribution to journalArticle

Abstract

Background: The relationship between the uptake of lactosaminated and intact N-succinyl-chitosans into hepatoma cells (MH134 and AH130) and liver metastatic tumour model cells (M5076) and the antitumour effects of their conjugates with mitomycin C (MMC) were investigated. Materials and Methods: Fluorescently-labelled carriers were administered to tumour-bearing mice. The fluorescence intensity and microscopic examinations were performed at 1 hour post-injection. The antitumour effects were examined according to several schedules: one of them was the administration of each conjugate at a dose of 4 mg eq. MMC/kg x 4 days at 3 days post-inoculation. Results: A difference in uptake was found by measurement of fluorescence intensity between both carriers only in MH134 cells, but was not recognized by fluorescence microscopy. Among these cell lines, the uptake of carriers into M5076 cells tended to be the most extensive. The difference in antitumour effects of the conjugates against MH134 and M5076 was reflected by the biodistribution study. Conclusion: The pattern of antitumour effects was markedly different among cell lines of different origins.

Original languageEnglish (US)
Pages (from-to)2771-2776
Number of pages6
JournalAnticancer Research
Volume22
Issue number5
StatePublished - Sep 2002
Externally publishedYes

Fingerprint

Mitomycin
Neoplasms
Fluorescence
Cell Line
Fluorescence Microscopy
Hepatocellular Carcinoma
Appointments and Schedules
Injections
N-succinyl-chitosan
Liver

Keywords

  • AH130
  • Antitumour effects
  • Lactosaminated N-succinylchitosan
  • M5076
  • MH134
  • N-succinyl-chitosan

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumour cell uptake of lactosaminated and intact N-succinylchitosans and antitumour effects of conjugates with mitomycin C. / Kato, Yoshinori; Onishi, Hiraku; Machida, Yoshiharu.

In: Anticancer Research, Vol. 22, No. 5, 09.2002, p. 2771-2776.

Research output: Contribution to journalArticle

Kato, Yoshinori ; Onishi, Hiraku ; Machida, Yoshiharu. / Tumour cell uptake of lactosaminated and intact N-succinylchitosans and antitumour effects of conjugates with mitomycin C. In: Anticancer Research. 2002 ; Vol. 22, No. 5. pp. 2771-2776.
@article{8d8cff99a0464212b7ef1a67dcb911f7,
title = "Tumour cell uptake of lactosaminated and intact N-succinylchitosans and antitumour effects of conjugates with mitomycin C",
abstract = "Background: The relationship between the uptake of lactosaminated and intact N-succinyl-chitosans into hepatoma cells (MH134 and AH130) and liver metastatic tumour model cells (M5076) and the antitumour effects of their conjugates with mitomycin C (MMC) were investigated. Materials and Methods: Fluorescently-labelled carriers were administered to tumour-bearing mice. The fluorescence intensity and microscopic examinations were performed at 1 hour post-injection. The antitumour effects were examined according to several schedules: one of them was the administration of each conjugate at a dose of 4 mg eq. MMC/kg x 4 days at 3 days post-inoculation. Results: A difference in uptake was found by measurement of fluorescence intensity between both carriers only in MH134 cells, but was not recognized by fluorescence microscopy. Among these cell lines, the uptake of carriers into M5076 cells tended to be the most extensive. The difference in antitumour effects of the conjugates against MH134 and M5076 was reflected by the biodistribution study. Conclusion: The pattern of antitumour effects was markedly different among cell lines of different origins.",
keywords = "AH130, Antitumour effects, Lactosaminated N-succinylchitosan, M5076, MH134, N-succinyl-chitosan",
author = "Yoshinori Kato and Hiraku Onishi and Yoshiharu Machida",
year = "2002",
month = "9",
language = "English (US)",
volume = "22",
pages = "2771--2776",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Tumour cell uptake of lactosaminated and intact N-succinylchitosans and antitumour effects of conjugates with mitomycin C

AU - Kato, Yoshinori

AU - Onishi, Hiraku

AU - Machida, Yoshiharu

PY - 2002/9

Y1 - 2002/9

N2 - Background: The relationship between the uptake of lactosaminated and intact N-succinyl-chitosans into hepatoma cells (MH134 and AH130) and liver metastatic tumour model cells (M5076) and the antitumour effects of their conjugates with mitomycin C (MMC) were investigated. Materials and Methods: Fluorescently-labelled carriers were administered to tumour-bearing mice. The fluorescence intensity and microscopic examinations were performed at 1 hour post-injection. The antitumour effects were examined according to several schedules: one of them was the administration of each conjugate at a dose of 4 mg eq. MMC/kg x 4 days at 3 days post-inoculation. Results: A difference in uptake was found by measurement of fluorescence intensity between both carriers only in MH134 cells, but was not recognized by fluorescence microscopy. Among these cell lines, the uptake of carriers into M5076 cells tended to be the most extensive. The difference in antitumour effects of the conjugates against MH134 and M5076 was reflected by the biodistribution study. Conclusion: The pattern of antitumour effects was markedly different among cell lines of different origins.

AB - Background: The relationship between the uptake of lactosaminated and intact N-succinyl-chitosans into hepatoma cells (MH134 and AH130) and liver metastatic tumour model cells (M5076) and the antitumour effects of their conjugates with mitomycin C (MMC) were investigated. Materials and Methods: Fluorescently-labelled carriers were administered to tumour-bearing mice. The fluorescence intensity and microscopic examinations were performed at 1 hour post-injection. The antitumour effects were examined according to several schedules: one of them was the administration of each conjugate at a dose of 4 mg eq. MMC/kg x 4 days at 3 days post-inoculation. Results: A difference in uptake was found by measurement of fluorescence intensity between both carriers only in MH134 cells, but was not recognized by fluorescence microscopy. Among these cell lines, the uptake of carriers into M5076 cells tended to be the most extensive. The difference in antitumour effects of the conjugates against MH134 and M5076 was reflected by the biodistribution study. Conclusion: The pattern of antitumour effects was markedly different among cell lines of different origins.

KW - AH130

KW - Antitumour effects

KW - Lactosaminated N-succinylchitosan

KW - M5076

KW - MH134

KW - N-succinyl-chitosan

UR - http://www.scopus.com/inward/record.url?scp=0036766002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036766002&partnerID=8YFLogxK

M3 - Article

C2 - 12529995

AN - SCOPUS:0036766002

VL - 22

SP - 2771

EP - 2776

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -